Company facts
- Headquarters
- Kowloon
- Most recent report
- 6-K, filed Sep 24, 2026
- Filings on record
- 66 filings
- On EDGAR
- CIK 2007702
- Fiscal year ends
- March
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 17
- 6-K Report a foreign issuer made public elsewhere Sep 24, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 23, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 10, 2026
- 20-F Annual report, foreign issuer Aug 7, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 16, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 27, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 18, 2026
- 6-K Report a foreign issuer made public elsewhere Jan 16, 2026
Prospectuses and Registrations 6
Ownership 8 of 11
- 3 Insider reported their initial holding Jun 12, 2026
- 3 Insider reported their initial holding Jun 10, 2026
- 3 Insider reported their initial holding Jun 9, 2026
- 3 Insider reported their initial holding Jun 8, 2026
- 3 Insider reported their initial holding Jun 8, 2026
- 3 Insider reported their initial holding Jun 8, 2026
- 3 Insider reported their initial holding Jun 8, 2026
- SCHEDULE 13D Large holder reported an active stake Nov 12, 2025
Other 8 of 32
- NT 20-F Jul 31, 2026
- EFFECT Notice that a registration became effective Jun 24, 2026
- EFFECT Notice that a registration became effective Apr 8, 2026
- CORRESP Reply to SEC staff Apr 6, 2026
- UPLOAD Comment letter from SEC staff Apr 2, 2026
- NT 20-F Jul 31, 2025
- CERT Exchange certified a listing Jan 13, 2025
- 8-A12B Registration of a security for exchange listing Jan 8, 2025
Everything here comes from Cellyan Biotechnology Co., Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.